CSIMarket
 


Frequency Therapeutics Inc   (FREQ)
Other Ticker:  
 

Cumulative Frequency Therapeutics Inc 's Working Capital Ratio for Trailing Twelve Months Period

FREQ's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

FREQ Working Capital Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth 90.78 % 85.59 % -35.66 % -57.09 % -68.15 %
Y / Y Current Assets Growth -32.63 % -34.2 % -40.05 % -40.13 % -34.06 %
Working Capital Ratio for Trailing Twelve Months Period 7.77 10.19 13.38 13.18 11.49
Total Ranking # 519 # 535 # 405 # 447 # 392
Seq. Current Liabilities Growth 19.34 % 37.7 % 6.5 % 9 % 16.1 %
Seq. Current Assets Growth -10.96 % -5.43 % -10.99 % -10.11 % -13.03 %


Working Capital Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to increase in Current Liabilities in the III. Quarter to $20 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 7.77 below Frequency Therapeutics Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 193 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Frequency Therapeutics Inc . While Working Capital Ratio for Trailing Twelve Months Period overall ranking has improved so far to 519, from total ranking in previous quarter at 535.

What is Working Capital Ratio?
More about FREQ
Working Capital Ratio FREQ in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 194
Sector # 321
S&P 500 # 518


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
13.38 8.27 3.7
(Mar 31 2022)   (Mar 31 2020)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Working Capital Ratio for Trailing Twelve Months Period
Kinnate Biopharma Inc   21.17 
Generation Bio Co   21.16 
Pardes Biosciences Inc   20.85 
Rallybio Corporation  20.84 
Nkarta Inc   20.57 
Biomea Fusion Inc   20.50 
Seres Therapeutics Inc   19.94 
Io Biotech Inc   19.90 
Minerva Neurosciences Inc   19.51 
Keros Therapeutics Inc   19.41 
Kronos Bio Inc   19.33 
Genprex Inc   19.30 
Painreform Ltd  19.19 
Sage Therapeutics Inc   19.11 
Lantern Pharma Inc   19.00 
Reviva Pharmaceuticals Holdings Inc   18.86 
Enlivex Therapeutics Ltd   18.77 
Reneo Pharmaceuticals Inc   18.77 
Forte Biosciences Inc   18.54 
Kempharm Inc  18.51 
Alx Oncology Holdings Inc  18.49 
Oric Pharmaceuticals Inc   18.28 
Morphic Holding inc   18.28 
Savara Inc   18.19 
Milestone Pharmaceuticals Inc   18.17 
Hcw Biologics Inc   18.07 
Erasca Inc   18.04 
Eledon Pharmaceuticals Inc   18.01 
Centessa Pharmaceuticals Plc  17.82 
Pasithea Therapeutics Corp   17.81 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EUDA's Profile

Stock Price

EUDA's Financials

Business Description

Fundamentals

Charts & Quotes

EUDA's News

Suppliers

EUDA's Competitors

Customers & Markets

Economic Indicators

EUDA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071